Source:http://linkedlifedata.com/resource/pubmed/id/20837533
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
39
|
pubmed:dateCreated |
2010-9-30
|
pubmed:abstractText |
We present an allele-specific copy number analysis of the in vivo breast cancer genome. We describe a unique bioinformatics approach, ASCAT (allele-specific copy number analysis of tumors), to accurately dissect the allele-specific copy number of solid tumors, simultaneously estimating and adjusting for both tumor ploidy and nonaberrant cell admixture. This allows calculation of "ASCAT profiles" (genome-wide allele-specific copy-number profiles) from which gains, losses, copy number-neutral events, and loss of heterozygosity (LOH) can accurately be determined. In an early-stage breast carcinoma series, we observe aneuploidy (>2.7n) in 45% of the cases and an average nonaberrant cell admixture of 49%. By aggregation of ASCAT profiles across our series, we obtain genomic frequency distributions of gains and losses, as well as genome-wide views of LOH and copy number-neutral events in breast cancer. In addition, the ASCAT profiles reveal differences in aberrant tumor cell fraction, ploidy, gains, losses, LOH, and copy number-neutral events between the five previously identified molecular breast cancer subtypes. Basal-like breast carcinomas have a significantly higher frequency of LOH compared with other subtypes, and their ASCAT profiles show large-scale loss of genomic material during tumor development, followed by a whole-genome duplication, resulting in near-triploid genomes. Finally, from the ASCAT profiles, we construct a genome-wide map of allelic skewness in breast cancer, indicating loci where one allele is preferentially lost, whereas the other allele is preferentially gained. We hypothesize that these alternative alleles have a different influence on breast carcinoma development.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1091-6490
|
pubmed:author |
pubmed-author:Børresen-DaleAnne-LiseAL,
pubmed-author:KristensenVessela NVN,
pubmed-author:LingjærdeOle ChristianOC,
pubmed-author:MarynenPeterP,
pubmed-author:NaumeBjørnB,
pubmed-author:NordgardSilje HSH,
pubmed-author:PerouCharles MCM,
pubmed-author:RussnesHege GHG,
pubmed-author:RyeInga HIH,
pubmed-author:SunWeiW,
pubmed-author:Van LooPeterP,
pubmed-author:WeigmanVictor JVJ,
pubmed-author:ZetterbergAndersA
|
pubmed:issnType |
Electronic
|
pubmed:day |
28
|
pubmed:volume |
107
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
16910-5
|
pubmed:meshHeading |
pubmed-meshheading:20837533-Alleles,
pubmed-meshheading:20837533-Breast Neoplasms,
pubmed-meshheading:20837533-Carcinoma,
pubmed-meshheading:20837533-Female,
pubmed-meshheading:20837533-Gene Dosage,
pubmed-meshheading:20837533-Genes, Neoplasm,
pubmed-meshheading:20837533-Genome, Human,
pubmed-meshheading:20837533-Humans,
pubmed-meshheading:20837533-Ploidies
|
pubmed:year |
2010
|
pubmed:articleTitle |
Allele-specific copy number analysis of tumors.
|
pubmed:affiliation |
Department of Genetics, Institute for Cancer Research, Clinic for Cancer and Surgery, Oslo University Hospital, Montebello, N-0310 Oslo, Norway.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|